FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the pharmaceutical industry and medicine. What is presented is using treo-3-phenylglutamic acid hydrochloride of the following structural formula: as an agent possessing the cardioprotective, antiplatelet, anticoagulant and membrane-protective properties under stress stimulation.
EFFECT: compound possesses the high cardioprotective, antiplatelet, anticoagulant and membrane-protective activity.
9 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSIVE CARDIOPROTECTIVE ACTION UNDER STRESS STIMULATION | 2013 |
|
RU2531082C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
METHOD OF CORRECTING AGGRESSIVE BEHAVIOR CAUSED BY CHRONIC MODERATE STRESS | 2019 |
|
RU2714934C1 |
AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
ETHYLIDENE HYDRAZIDE OF 2-[6-METHYL-1-(THIETHAN-3-YL)URACYL-3-YL]ACETIC ACID, DEMONSTRATING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2539301C1 |
SALT OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE WITH FUMARIC ACID, POSSESSING METABOLIC AND CARDIOPROTECTIVE ACTIVITY, AND METHOD OF ITS OBTAINING | 2008 |
|
RU2365582C1 |
PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
METHOD FOR DETERMINING ERYTHROCYTE ADRENAL RESPONSIVENESS | 2011 |
|
RU2471189C1 |
Authors
Dates
2014-10-20—Published
2013-10-24—Filed